A Novel Polymorphism in Intron 6 of the Human p53 Gene: A Possible Association with Cancer Predisposition and Susceptibility
- 1 December 1995
- journal article
- research article
- Published by Mary Ann Liebert Inc in DNA and Cell Biology
- Vol. 14 (12) , 983-990
- https://doi.org/10.1089/dna.1995.14.983
Abstract
We present a novel polymorphic 8-bp sequence in intron 6 of the p53 gene that maps between bp 55 and 62 of the 3′ end of exon 6. Of normal blood samples, 32% were heterozygotic for this polymorphism and display a NN′ genotype, whereas 68% of the population is homozygotic for the N genotype. The rare homozygotic genotype N′ was detected only in four blood samples of cancer patients. Peripheral blood of gastrointestinal (GI) and breast tumor patients demonstrated a higher incidence of heterozygosity (50%) than that of normal individuals. Analysis of the distribution of this polymorphism in tumor samples showed loss of heterozygosity (LOH). This LOH during tumor progression could exhibit preference to each one of the polymorphic alleles. The rare presentation of one allele and the increased incidence of heterozygosity in carcinoma patients may suggest an association between this polymorphism with cancer predisposition and susceptibility. The fact that genetic alterations occurring in noncoding regions may play a role in tumor development only further increases the extent of involvement of p53 in carcinogenesis.Keywords
This publication has 38 references indexed in Scilit:
- p53 mutations in matched primary and metastatic human tumorsMolecular Carcinogenesis, 1995
- The intronic structure of cancer-related genes regulates susceptibility to cancerMolecular Carcinogenesis, 1994
- Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancerCarcinogenesis: Integrative Cancer Research, 1994
- Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinomaHepatology, 1994
- The Importance of p53 Gene Alterations in Human Cancer: Is There More Than Circumstantial Evidence?JNCI Journal of the National Cancer Institute, 1993
- TP53 tumor suppressor gene: A model for investigating human mutagenesisGenes, Chromosomes and Cancer, 1992
- p53 Mutations in Human CancersScience, 1991
- A splicing mutation accounts for the lack of p53 gene expression in a CML blast crisis cell line: a novel mechanism of p53 gene inactivationBritish Journal of Haematology, 1990
- Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer.Journal of Clinical Investigation, 1990
- p53: A Frequent Target for Genetic Abnormalities in Lung CancerScience, 1989